… Panellists will address the following questions: How has the Covid-19 pandemic influenced the advancement of RNA research? What does the investment landscape look like…
…50 countries. It is the most common and fastest growing Covid-19 subvariant in the US, estimated to be responsible for around 17% of current Covid-19 cases, according to the Centers…
…other research has shown that Covid-19 may also reduce AHR activity in the lung. It will be interesting to investigate the impact of other respiratory viruses on AHR, and also…
In preclinical studies, a new pan-coronavirus papain-like protease (PLpro) inhibitor has shown a near complete reduction in SARS-CoV-2 viral load in the lungs. Infex Therapeutics has selected the clinical candidate…
…a new pandemic threat. Commenting on the opening, Janet Valentine, ABPI Executive Director, Innovation and Research Policy, said: “The Covid-19 pandemic taught us that through extraordinary interventions and public sacrifice…
…ninth Covid-19 vaccine to be authorised by the UK’s independent medicines regulator. Bimervax combines a part of the SARS-CoV-2 virus spike protein with an adjuvant. It is approved as a…
…genes associated with long Covid for the first time, while a Stanford University probe found that neuroscience research data had been falsified. You can listen below, or find The Drug…
…(SCCHN) with its lead NOX 1 and 4 inhibitor product candidate, setanaxib. Ground-breaking study identifies novel drug targets for long Covid A study into long Covid has provided the first…
…a combinatorial analytics approach to compare subpopulations of long Covid patients from Sano Genetics’ long Covid GOLD study. The analysis identified 73 genes that were highly associated with severe and…
…results of its mid-year global analysis of all clinical trials conducted in 2023 to date. The analysis reveals that Covid-19 is no longer one of the top five most studied…
…could allow some patients to become insulin-independent, and a new study linked severe Covid-19 outcomes with high levels of antibiotics use. You can listen below, or find The Drug Discovery…
…Severe Covid-19 linked to antibiotics overuse Frequent and diverse use of antibiotics may be associated with developing more severe outcomes after a Covid-19 infection, including death, UK scientists have shown….
…experiencing severe Covid-19 outcomes, including hospital admission and 30-day mortality. Plus, using a range of antibiotics was more likely to be associated with Covid-19 hospital admission. Co-principal investigator Professor Tjeerd…
Biopharmaceutical company InflaRx has launched Gohibic (vilobelimab) in the US for the treatment of Covid-19. In April 2023, Gohibic was granted an Emergency Use Authorization (EUA) by the US Food…
